CoChat

Spatiotemporal analysis of tumour-infiltrating immune cells in biliary carcinogenesis

Open access

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

Background: Intraductal papillary neoplasms (IPN) and biliary epithelial neoplasia (BilIN) are well‐defined precursor lesions of biliary tract carcinoma (BTC). The aim of this study was to provide a comprehensive characterisation of the inflammatory microenvironment in BTC precursor lesions. Methods: Immunohistochemistry was employed to assess tumour-infiltrating immune cells in tissue samples from patients, for whom precursor lesions were identified alongside invasive BTC. The spatiotemporal evolution of the immune microenvironment during IPN-associated carcinogenesis was comprehensively analysed using triplet sample sets of non-neoplastic epithelium, precursor lesion and invasive BTC. Immune-cell dynamics during IPN- and BilIN-associated carcinogenesis were subsequently compared. Results: Stromal CD3+(P = 0.002), CD4+(P = 0.007) and CD8+(P < 0.001) T cells, CD20+B cells (P = 0.008), MUM1+plasma cells (P = 0.012) and CD163+M2-like macrophages (P = 0.008) significantly decreased in IPN compared to non-tumorous biliary epithelium. Upon transition from IPN to invasive BTC, stromal CD68+(P = 0.001) and CD163+(P < 0.001) macrophages significantly increased. In contrast, BilIN-driven carcinogenesis was characterised by significant reduction of intraepithelial CD8+T-lymphocytic infiltration from non-tumorous epithelium via BilIN (P = 0.008) to BTC (P = 0.004). Conclusion: IPN and BilIN are immunologically distinct entities that undergo different immune-cell variations during biliary carcinogenesis. Intraepithelial CD8+T-lymphocytic infiltration of biliary tissue decreased already at the IPN-precursor stage, whereas BilIN-associated carcinogenesis showed a slowly progressing reduction towards invasive carcinoma.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41416-022-01933-0

Cites

Statistics

Figures

Fig. 1 Study design and cohort characterisation. a A total of 139 patients with biliary tract cancer precursor lesions were included in this study: n = 65 high-grade intraductal papillary neoplasms of the biliary tract (IPNB/ITPN), n = 74 high-grade BilIN and their associated invasive and non-tumorous counterparts were selected for tissue microarray construction. Scale bars represent 100 µm. Images were acquired at ×20 magnification. b Representative immunohistochemical staining of a tissue microarray dot showing CD8+ lymphocytes in the stromal (S) and intraepithelial (E) compartments of IPNB tissue. c Kaplan–Meier survival curves of IPN- and BilIN-associated cases.
Fig. 1 Study design and cohort characterisation. a A total of 139 patients with biliary tract cancer precursor lesions were included in this study: n = 65 high-grade intraductal papillary neoplasms of the biliary tract (IPNB/ITPN), n = 74 high-grade BilIN and their associated invasive and non-tumorous counterparts were selected for tissue microarray construction. Scale bars represent 100 µm. Images were acquired at ×20 magnification. b Representative immunohistochemical staining of a tissue microarray dot showing CD8+ lymphocytes in the stromal (S) and intraepithelial (E) compartments of IPNB tissue. c Kaplan–Meier survival curves of IPN- and BilIN-associated cases.CC BY · PubMed Central
Fig. 2 Distribution of total and stromal inflammatory cell infiltrates in intraductal papillary neoplasms of the biliary tract (IPN), their associated invasive BTC (INV) and non-tumorous tissue (NT). a–h Total and stromal counts of a CD3+ T lymphocytes (NT: n = 56; IPN: n = 65; INV: n = 41), b CD4+ T lymphocytes (NT: n = 57; IPN: n = 65; INV: n = 41), c CD8+ T lymphocytes (NT: n = 57; IPN: n = 65; INV: n = 41), d CD20+ B lymphocytes (NT: n = 60; IPN: n = 65; INV: n = 43), e MUM1+ plasma cells (NT: n = 59; IPN: n = 65; INV: n = 42), f CD68+ macrophages (NT: n = 58; IPN: n = 65; INV: n = 42), g CD163+ macrophages (NT: n = 56; IPN: n = 65; INV: n = 42) and h CD56+ NK cells (NT: n = 57; IPN: n = 65; INV: n = 44). Significant P values of Kruskal–Wallis test are shown in bold, followed by Dunn’s post hoc analysis. *P < 0.05, **P < 0.01, ***P < 0.001; ns not significant, NA not applicable.
Fig. 2 Distribution of total and stromal inflammatory cell infiltrates in intraductal papillary neoplasms of the biliary tract (IPN), their associated invasive BTC (INV) and non-tumorous tissue (NT). a–h Total and stromal counts of a CD3+ T lymphocytes (NT: n = 56; IPN: n = 65; INV: n = 41), b CD4+ T lymphocytes (NT: n = 57; IPN: n = 65; INV: n = 41), c CD8+ T lymphocytes (NT: n = 57; IPN: n = 65; INV: n = 41), d CD20+ B lymphocytes (NT: n = 60; IPN: n = 65; INV: n = 43), e MUM1+ plasma cells (NT: n = 59; IPN: n = 65; INV: n = 42), f CD68+ macrophages (NT: n = 58; IPN: n = 65; INV: n = 42), g CD163+ macrophages (NT: n = 56; IPN: n = 65; INV: n = 42) and h CD56+ NK cells (NT: n = 57; IPN: n = 65; INV: n = 44). Significant P values of Kruskal–Wallis test are shown in bold, followed by Dunn’s post hoc analysis. *P < 0.05, **P < 0.01, ***P < 0.001; ns not significant, NA not applicable.CC BY · PubMed Central
Fig. 3 Distribution of intraepithelial inflammatory cell infiltrates in intraductal papillary neoplasms of the biliary tract (IPN), their associated invasive BTC (INV) and non-tumorous tissue (NT). a Percentage of cases showing any positive intraepithelial inflammatory cells in NT, IPN and INV. Significant P values of Pearson’s chi-squared test are shown in bold. b–d Proportion per 100 biliary epithelial cells of intraepithelial, b CD3+ T lymphocytes, c CD4+ T lymphocytes, d CD8+ T lymphocytes. Significant P values of Kruskal–Wallis test are shown in bold, followed by Dunn’s post hoc analysis. e Spearman’s correlation between all assessed inflammatory parameters in intraductal papillary lesions (IPN). Significant correlations were marked with asterisks: *P < 0.05; **P < 0.01; ***P < 0.001; ns not significant, NA not applicable.
Fig. 3 Distribution of intraepithelial inflammatory cell infiltrates in intraductal papillary neoplasms of the biliary tract (IPN), their associated invasive BTC (INV) and non-tumorous tissue (NT). a Percentage of cases showing any positive intraepithelial inflammatory cells in NT, IPN and INV. Significant P values of Pearson’s chi-squared test are shown in bold. b–d Proportion per 100 biliary epithelial cells of intraepithelial, b CD3+ T lymphocytes, c CD4+ T lymphocytes, d CD8+ T lymphocytes. Significant P values of Kruskal–Wallis test are shown in bold, followed by Dunn’s post hoc analysis. e Spearman’s correlation between all assessed inflammatory parameters in intraductal papillary lesions (IPN). Significant correlations were marked with asterisks: *P < 0.05; **P < 0.01; ***P < 0.001; ns not significant, NA not applicable.CC BY · PubMed Central
Fig. 4 Distribution of inflammatory cell infiltrates in biliary intraepithelial neoplasia (BilIN), their associated invasive BTC (INV) and non-tumorous tissue (NT). a–d Total number of a CD4+ T lymphocytes (NT: n = 38; BilIN: n = 56; INV: n = 68), b CD8+ T lymphocytes (NT: n = 42; BilIN: n = 65; INV: n = 66), c CD20+ B lymphocytes (NT: n = 46; BilIN: n = 65; INV: n = 69) and d CD68+ macrophages (NT: n = 48; BilIN: n = 66; INV: n = 69). e Percentage of cases showing intraepithelial inflammatory cells in NT, IPN and INV. f–i Proportion per 100 biliary epithelial cells of intraepithelial, f CD4+ T lymphocytes, g CD8+ T lymphocytes, h CD20+ B lymphocytes and i CD68+ macrophages. Significant P values of Kruskal–Wallis (a–d, f–i) followed by Dunn’s post hoc analysis and Pearson’s chi-squared test (e) are shown in bold. *P < 0.05, **P < 0.01, ***P < 0.001; ns not significant, NA not applicable.
Fig. 4 Distribution of inflammatory cell infiltrates in biliary intraepithelial neoplasia (BilIN), their associated invasive BTC (INV) and non-tumorous tissue (NT). a–d Total number of a CD4+ T lymphocytes (NT: n = 38; BilIN: n = 56; INV: n = 68), b CD8+ T lymphocytes (NT: n = 42; BilIN: n = 65; INV: n = 66), c CD20+ B lymphocytes (NT: n = 46; BilIN: n = 65; INV: n = 69) and d CD68+ macrophages (NT: n = 48; BilIN: n = 66; INV: n = 69). e Percentage of cases showing intraepithelial inflammatory cells in NT, IPN and INV. f–i Proportion per 100 biliary epithelial cells of intraepithelial, f CD4+ T lymphocytes, g CD8+ T lymphocytes, h CD20+ B lymphocytes and i CD68+ macrophages. Significant P values of Kruskal–Wallis (a–d, f–i) followed by Dunn’s post hoc analysis and Pearson’s chi-squared test (e) are shown in bold. *P < 0.05, **P < 0.01, ***P < 0.001; ns not significant, NA not applicable.CC BY · PubMed Central
Fig. 5 Changes in immune-cell distribution throughout IPN- and BilIN-associated carcinogenesis. a–d Each bar represents the mean fold change of total cell counts or intraepithelial cell percentages between (a, b) non-tumorous to dysplastic tissue and (c, d) between dysplastic and invasive tissue. Asterisks above bars indicate significance for comparisons shown in Figs. 2, 3 and 4. *P < 0.05, **P < 0.01, ***P < 0.001.
Fig. 5 Changes in immune-cell distribution throughout IPN- and BilIN-associated carcinogenesis. a–d Each bar represents the mean fold change of total cell counts or intraepithelial cell percentages between (a, b) non-tumorous to dysplastic tissue and (c, d) between dysplastic and invasive tissue. Asterisks above bars indicate significance for comparisons shown in Figs. 2, 3 and 4. *P < 0.05, **P < 0.01, ***P < 0.001.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 60 · Cited by 11

Research works printed but not linked: 1

  1. Howlader NNA, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, et al. (eds). SEER cancer statistics review. Bethesda, MD: National Cancer Institute; 1975–2018 [based on November 2020 SEER data submission].

Metadata

Authors
Charbel, A., Tavernar, L., Albrecht, T., Brinkmann, F., Verheij, J., Roos, E., Vogel, M. N., Köhler, B., Springfeld, C., Brobeil, A., Schirmacher, P., Singer, S., Mehrabi, A., Roessler, S., & Goeppert, B.
Affiliations
  • Heidelberg University (DE)
  • Amsterdam University Medical Centers (NL)
  • University Hospital Heidelberg (DE)
  • University of Tübingen (DE)
Corresponding author
  • Roessler, Stephanie
  • Goeppert, Benjamin
Venue
British Journal of Cancer
Published
2022-09-06
Volume
127
Issue
9
Pages
1603-1614
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W4294755646
Cited by
11
References
60
Citations by year
2026: 5 · 2025: 2 · 2024: 1 · 2023: 2 · 2022: 1
FWCI
1.43
Type
journal article
Language
en
Open access
Licence
Locations
  • British Journal of Cancer (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • Pure Amsterdam UMC (submittedVersion, cc-by)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (submittedVersion, other-oa)
Funders
  • PSC Partners Seeking a Cure
  • Deutsche Forschungsgemeinschaft (SFB/TRR 209, and Z01, 314905040)
Topics
  • Health Sciences › Medicine › Surgery › Cholangiocarcinoma and Gallbladder Cancer Studies
  • Health Sciences › Medicine › Gastroenterology › Gallbladder and Bile Duct Disorders
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
Keywords
biliary tract cancer, intraductal papillary neoplasm, biliary intraepithelial neoplasia, tumor-infiltrating immune cells, tumor immune microenvironment, CD8+ T cells, M2 macrophages, CD163, plasma cells, CD4+ T cells, CD20+ B cells, spatiotemporal evolution, carcinogenesis, precursor lesions
MeSH terms
Bile Duct Neoplasms, Bile Ducts, Intrahepatic, Bile Pigments, Biliary Tract, Biliary Tract Neoplasms, Humans, Cholangiocarcinoma, Tumor Microenvironment, Spatio-Temporal Analysis, Carcinogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Spatiotemporal analysis of tumour-infiltrating immune cells in biliary carcinogenesis. https://app.cochat.ai/papers/10.1038/s41416-022-01933-0
The paper
Charbel, A., Tavernar, L., Albrecht, T., Brinkmann, F., Verheij, J., Roos, E., Vogel, M. N., Köhler, B., Springfeld, C., Brobeil, A., Schirmacher, P., Singer, S., Mehrabi, A., Roessler, S., & Goeppert, B. (2022). Spatiotemporal analysis of tumour-infiltrating immune cells in biliary carcinogenesis. British Journal of Cancer. https://doi.org/10.1038/s41416-022-01933-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.